Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...
Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...
Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...
Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...
In urothelial bladder cancer, increased T cell infiltration has been correlated with longer patient survival. Previous clinical studies with an FGFR inhibitor, rogaratinib, demonstrated that the ...
Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients ...
CG Oncology stock is up 7% following bladder cancer data released by Johnson & Johnson. Read more here.
In vivo, using the subcutaneous MB49 bladder cancer model, HSV5-15 virus expressing both the cytokine and TLR agonist ...
Longer follow-up from the phase 3 AMBASSADOR trial showed adjuvant pembrolizumab to demonstrate a statistically significant ...